Expression of soluble CD27 and interleukins-8 and -10 in B-cell chronic lymphocytic leukemia: Correlation with disease stage and prognosis

Advances in Therapy

Volumn 24, Issue 1, 2007, Pages 29-40

  Kara, Ismail Oguz ^a   Sahin, Berksoy ^a   Gunesacar, Ramazan ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

B cell; B CLL; CD27; IL 10; IL 8

Indexed keywords

BETA 2 MICROGLOBULIN; CD27 ANTIGEN; CD38 ANTIGEN; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 8; LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT;

ADULT; AGED; ANTIGENS, CD27; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-8; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS;

EID: 34247850857     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02849990     Document Type: Article

References (50)

1. Kipps T. Chronic lymphocytic leukemia and related disorders. In: Beutler E, Lichtman M, Coller B, Kipps T, Seligsohn U, eds. Williams Hematology, 6th ed. New York, NY: McGraw-Hill Health Professions Division; 2001:1163-1194.
2. Skinnider LF, Tan L, Schmidt J, Armitage G. Chronic lymphocytic leukemia: a review of 745 cases and assessment of clinical staging. Cancer. 1982;50:2951-2955.
3. Spati B, Child JA, Kerruish SM, Cooper EH. Behaviour of serum beta 2-microglobulin and acute phase reactant proteins in chronic lymphocytic leukaemia: a multicentre study. Acta Haematol. 1980;64:79-86.
4. Molica S, Levato D, Cascavilla N, Levato L, Musto P. Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta2-microglobulin in B-cell chronic lymphocytic leukemia. Eur J Haematol. 1999;62:117-122.
5. Sarfati M, Chevret S, Chastang C, et al. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood. 1996;88:4259-4264.
6. van Oers MH, Pals ST, Evers LM, et al. Expression and release of CD27 in human B-cell malignancies. Blood. 1993;82:3430-3436.
7. Molica S, Vitelli G, Levato D, et al. CD27 in B-cell chronic lymphocytic leukemia: cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily. Haematologica. 1998;83:398-402.
8. Lee JS, Dixon DO, Kantarjian HM, Keating MJ, Talpaz M. Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients. Blood. 1987;69:929-936.
9. Dohner H, Stilgenbauer S, James MR, et al. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood. 1997;89:2516-2522.
10. Cordone I, Masi S, Mauro FR, et al. p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis. Blood. 1998;91:4342-4349.
11. DamLe RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840-1847.
12. Del Poeta G, Maurillo L, Venditti A, et al. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood. 2001;98:2633-2639.
13. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V (H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848-1854.
14. Montserrat E, Marques-Pereira JP, Gallart MT, Rozman C. Bone marrow histopathologic patterns and immunologic findings in B-cell chronic lymphocytic leukemia. Cancer. 1984;54:447-451.
15. Rassenti LZ, Huynh L, Toy TL, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med. 2004;351:893-901.
16. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Ann Rev Immunol. 1991;9:617-648.
17. di Celle PF, Carbone A, Marchis D, et al. Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein. Blood. 1994;84:220-228.
18. di Celle PF, Mariani S, Riera L, Stacchini A, Reato G, Foa R. Lnterleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood. 1996;87:4382-4389.
19. Fiorentine DF, Bond MW, Mosmann TR. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by the Th1 clones. J Exp Med. 1989;170:2081-2095.
20. Go NF, Castle BE, Barrett R, et al. lnterleukin-10 (IL-10), a new B-cell stimulatory factor: unresponsiveness of X-chromosome linked immunodeficiency B cells. J Exp Med. 1990;172:1625-1631.
21. Rousset F, Garcia E, Defrance T, et al. IL-10 is a potent growth factor for activated human B lymphocytes. Proc Natl Acad Sci USA. 1992;898:1890-1893.
22. Thompson-Snipes L, Dhar V, Bond MW, Mosmann TR, Moore KW, Rennick D. Interleukin-10: a novel stimulator factor for mast cells and their progenitors. J Exp Med. 1991;173:507-510.
23. Blay J-Y, Burdin N, Rousset F, et al. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood. 1993;82:2169-2174.
24. Cortes J, Kurzrock R. Interleukin-10 in non-Hodgkin's lymphoma. Leuk Lymphoma. 1997;28:251-259.
25. Cortes JE, Talpaz M, Cabanillas F, Seymour JF, Kurzrock R. Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis. Blood. 1995;85:2516-2520.
26. Blay J-Y, Voorzanger N, Favrot M, Burdin N, Rousset F, Banchereau J. Presence of Epstein-Barr virus viral interleukin-10 in the serum of patients with human immunodeficiency virus-related diffuse large-cell non-Hodgkin's lymphomas [letter]. Blood. 1995;86:4702-4707.
27. Sarris AH, Kliche K-O, Pethambaran P, et al. Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival. Ann Oncol. 1999;10:433-440.
28. Lotz M, Setareh M, von Kempis J, Schwarz H. The nerve growth factor/tumor necrosis factor receptor family. J Leuk Biol. 1996;60:1-7.
29. Gruss H-J, Dower SK. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood. 1995;85:3378-3404.
30. Rui H, Kirken RA, Duhe RJ, Howard OMZ, Evans GA, Farrar WL. Lymphokine-induced signal transduction. In: Townley R, Agrawal DK, eds. Immunopharmacology of Allergic Disease. New York, NY: Marcel Dekker, Inc.; 1996:29-77.
31. Van Lier RAW, Pool MO, Kabel P, et al. Anti-CD27 monoclonal antibodies identify two functionally distinct subpopulations within the CD4+ T cell subset. Eur J Immunol. 1988;18:811-816.
32. Kobata T, Jacquot S, Kozlowski S, Agematsu K, Schlossman SF, Morimoto C. CD27-CD70 interaction regulated B-cell activation by T-cells. Proc Natl Acad Sci USA. 1995;92:11249-11253.
33. Agematsu K, Kobata T, Feng-Chun Y, et al. CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. Eur J Immunol. 1995;25:2825-2829.
34. Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig) M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med. 1998;188:1679-1689.
35. Tangye SG, Liu Y-J, Aversa G, Phillips JH, deVries JE. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med. 1998;188:1691-1703.
36. Reed JC. Molecular biology of chronic lymphocytic leukemia. Semin Oncol. 1998;25:11-18.
37. Egle A, Marschitz I, Posch B, Herold M, Greil R. IL-10 serum levels in B-cell chronic lymphocytic leukemia. Br J Haematol. 1996;94:211-212.
38. Jurlander J, Lai CF, Tan J, et al. Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells. Blood. 1997;89:4146-4152.
39. Sjoberg J, Aguilar-Santelises M, Sjogren AM, et al. Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukemia inversely correlates with progression of disease. Br J Haematol. 1996;92:393-400.
40. Kamper EF, Papaphilis AD, Angelopoulou MK, et al. Serum levels of tetranectin, intracellular adhesion molecule-1 and interleukin-10 in B-cell chronic lymphocytic leukemia. Clin Biochem. 1999;32:639-645.
41. Knauf WU, Ehlers B, Bisson S, Thiel E. Serum levels of interleukin-10 in B-cell chronic lymphocytic leukemia. Blood. 1995;86:4382-4383.
42. Lee BN, Estrov Z, Huh Y, et al. Peripheral blood normal polyclonal B cells from patients with B-CLL produce B-cell stimulatory cytokines [abstract 2758]. Proc Am Assoc Cancer Res. 1998;36.
43. Tangye SG, Weston KM, Raison RL. Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD51 B-cells. Leuk Lymphoma. 1998;31:121-130.
44. Kitabayashi A, Kirokawa M, Miura AB. The role of interleukin-10 (IL-10) in chronic B-cell lymphocytic leukemia: IL-10 prevents leukemic cells from apoptotic cell death. Int J Hematol. 1995;62:99-106.
45. Fluckiger AC, Duran I, Banchereau J. Interleukin-10 induces apoptotic cell death of B-cell chronic lymphocytic leukemia cells. J Exp Med. 1994;179:91-99.
46. Levy C, Brouet JC. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest. 1994;93:424-428.
47. Baiocchi RA, Ross ME, Tan JC, et al. Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10. Blood. 1995;85:1063-1074.
48. Jewell AP, Worman CP, Lydyard PM, Yong KL, Giles FJ, Goldstone AH. Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. Br J Haematol. 1994;88:268-274.
49. Bushcle M, Campana D, Carding SR, Richard C, Hoffbrand AV, Brenner MK. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med. 1993;177:213-218.
50. Castejon R, Vargas JA, Romero Y, Briz M, Munoz RM, Durantez A. Modulation of apoptosis by cytokines in B-cell chronic lymphocytic leukemia. Cytometry. 1999;38:224-230.